Immune checkpoint inhibitor efficacy against glioblastoma may decrease with dexamethasone Michelle Palacino November 25, 2020 News Read more articles Previous PostWhy Young and Female Patients Don’t Respond as Well to Cancer Immunotherapy Next PostIvy Foundation grant aids Fralin Biomedical Research Institute scientist’s search for treatment for deadly brain cancer You Might Also Like TGen Receives Approval for Patient Enrollment in Brain Cancer Clinical Trial September 2, 2014 Ivy Foundation Project Kick-off Meeting Focuses on Collaboration January 23, 2009 Brain Tumor Patients Put on Fast Track in Revolutionary Clinical Trial March 10, 2015
